Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1573P - Anxiety and depression in cancer patients during the COVID-19 pandemic: A single-centre study

Date

17 Sep 2020

Session

E-Poster Display

Topics

Psychosocial Aspects of Cancer

Tumour Site

Presenters

Feryel Letaief-Ksontini

Citation

Annals of Oncology (2020) 31 (suppl_4): S898-S902. 10.1016/annonc/annonc286

Authors

F. Letaief-Ksontini, Y. Zenzri, Y. Yahyaoui, A. Gabsi, A. Mokrani, K. Meddeb, F. mghirbi, H. Rais, M. Ayadi, N. Chraiet, A. Mezlini

Author affiliations

  • Medecine Department, Institut Salah Azaïz, 1006 - Tunis/TN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1573P

Background

The COVID-19 pandemic has caused global mental health crisis. It has resulted in new sources of anxiety and depression among cancer patients which causes increasing psychological pressure. This study aimed at assessing the anxiety and depression in Tunisian cancer patients.

Methods

We conducted an observational, cross-sectional study between March and May 2020 during the COVID-19 pandemic. Symptoms of anxiety and depression in cancer patients were screened using the Hospital Anxiety and Depression Scale (HADS). A total of 91 patients replied to this survey.

Results

From a total of 91 respondents in the study, there were 48 (52.7%) male patients and 43 (47.3%) female patients. 59 (64.8%) of the patients involved in this study were above 40 years of age, followed by 17(18.7%) of 20-29 years old and 15(16.5%) of 30-39 years old. About marital status, 67(73.6%) were married, 5 (5.5%) divorced, 4(4.4%) widowed and 15 (16.5%) were single. The incidence of depression under novel coronavirus pandemic in cancer patients was 29.7% (27/91). Eighteen (66.7%) had mild depression, 7(25.9%) moderate depression and two (7.4%) severe depression. The incidence of anxiety was 69.2% (63/91).Of those patients, 42(66.7%) were experiencing mild anxiety, 12(19%) moderate anxiety and 9(14.3%) severe anxiety. Univariate analysis showed that asthenia, family support and pain were associated with anxiety (p=0.006, p=0.001 and p=0.009, respectively). Multivariate analysis of logistic regression revealed that family support during the COVID-19 pandemic was negatively correlated with the level of anxiety (p=0.01). Presence of pain was associated with anxiety (OR= 4.106; 95%CI, 1.011-16.672; p=0.048). There were no significant relationships between depression and sex, family support, type of cancer or pain.

Conclusions

This study provided evidence of high rates of depression and anxiety during the COVID-19 pandemic. Family support reduces the risk of anxiety while, presence of pain increases that risk.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Dr feryel Letaief KSONTINI.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.